This invention pertains to novel salt forms of trophenylethylene compound, such as 3-[4(1,2-diphenyl-but-1-enyl)-phenyl]-acrylic acid, as selective estrogen receptor modulators. This invention also provides methods for the treatment and/or prevention of breast, uterine, ovarian, prostrate and colon cancer, osteoporosis, cardiovascular disease, and benign proliferative disorders, as well as pharmaceutical compositions of the compounds of the present invention.

Esta invenção pertence aos formulários de sal da novela do composto do trophenylethylene, tais como o ácido 3-[4(1,2-diphenyl-but-1-enyl)-phenyl]-acrylic, como moduladores seletivos do receptor do estrogen. Esta invenção fornece também métodos para o tratamento e/ou a prevenção do peito, o cancer uterine, ovarian, prostrate e de dois pontos, o osteoporosis, doença cardiovascular, e disorders proliferative benignos, as.well.as composições pharmaceutical dos compostos da invenção atual.